Shebani Sethi

Stanford University

Shebani Sethi is a psychiatrist and researcher affiliated with Stanford University. Her work focuses on metabolic psychiatry, specifically the relationship between metabolic health and psychiatric conditions. Her published research examines the use of ketogenic and low-carbohydrate dietary interventions to treat serious mental illnesses, including schizophrenia, bipolar disorder, psychosis, obsessive-compulsive disorder, and binge eating disorders.

24 claims checked on air: 1 context 1 contradicted 1 overstated 18 supported 3 unverified

What they said on air - contradicted

0:23:16contradictedmoderateHow To Use Metabolic Psychiatry To Heal Your Anxiety & Depre

Metformin crosses the blood-brain barrier, supports the TCA cycle in mitochondria, and reduces inflammatory cytokines such as TNF-alpha and interleukin-6 in studies.

"For example, you could take metformin. A lot of us know metformin improves glucose, it improves insulin sensitivity, but it also crosses the blood-brain barrier and it has a neuroprotective effect. It helps in the TCA cycle. Within the mitochondria we have machinery to produce energy, to produce ATP, and there are deficits in that energy pathway, whether they're enzymes or co-factors they're not present. Metformin helps support that to some degree and it also does decrease inflammation. So in some studies it's been shown to reduce TNF-alpha, reduce interleukin-6, reduce other cytokines." (said at 0:23:16)

The claim bundles accurate and inaccurate assertions. Published evidence supports that metformin crosses the blood-brain barrier and exerts neuroprotective and anti-inflammatory effects, including suppressing microglial activation and reducing pro-inflammatory cytokines. However, the assertion that metformin supports the TCA cycle to produce ATP when mitochondrial machinery is deficient misstates its mitochondrial mechanism: metformin acts primarily as a mild inhibitor of mitochondrial complex I (NADH:ubiquinone oxidoreductase). This inhibition reduces ATP generation and alters the cellular AMP/ATP ratio to activate AMP-activated protein kinase (AMPK), rather than enhancing the TCA cycle or replacing missing enzymes to boost ATP production.

Fact-checked episodes

Publications